Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05983185 · ClinicalTrials.gov registry record · NA
Prism Adaptation Therapy (PAT) for Right Brain Stroke Rehabilitation
A NA study of Spatial Neglect After Right Brain Stroke, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 244
- Enrollment target
- 3
- Study locations
NCT05983185: Recruiting NA study of Spatial Neglect After Right Brain Stroke, sponsored by VA Office of Research and Development.
NCT05983185 is a NA study of Spatial Neglect After Right Brain Stroke that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 244 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05983185, a NA study of Spatial Neglect After Right Brain Stroke, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
- 3
- Study locations
Study Summary
After a right brain stroke, \>50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and their needs in the hospital and at home are greatly increased. An effective treatment for spatial neglect is 10 days of visuomotor training while wearing optical prisms (PAT), however many clinicians \[fail to diagnose spatial neglect and use this approach. In this study, the investigators will develop a brain scanning test that could objectively identify the Veterans with spatial neglect after stroke who are the best candidates to receive PAT and recover their ability to function. When the research is complete, the investigators expect that brain scans done in the hospital can guide the team to refer Veterans to PAT rehabilitation: improving daily life function\] and quality of life.
Primary Outcome
This variable is assignment to category defining spatial neglect. This is based on a data collection with computerized line bisection, which generates a profile score. Veterans whose computerized line bisection profile score indicates that they have spatial neglect that primarily affects movement, intention and action have Aiming SN; these Veterans responded best to prism adaptation therapy (PAT) in prior research. Alternately, Veterans may have a profile score consistent with Where SN, affectin
Conditions Studied
Interventions
- BEHAVIORAL Prism adaptation therapy
Study Locations (3)
Georgia
- Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur
Massachusetts
- VA Central Western Massachusetts Healthcare System, Leeds, MA - Leeds
Ohio
- Louis Stokes VA Medical Center, Cleveland, OH - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05983185 shows while recruiting
NCT05983185 is an interventional study that assigns participants to a tested intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Spatial Neglect After Right Brain Stroke appearing as the primary indexed condition, and to 1 intervention - of which Prism adaptation therapy is the first listed.
NCT05983185 reports a single indexed study location in Georgia, Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT05983185 about?
NCT05983185 is a clinical study titled "Prism Adaptation Therapy (PAT) for Right Brain Stroke Rehabilitation". After a right brain stroke, \>50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and thei...
What is the current status of trial NCT05983185?
This trial is currently recruiting. It is a NA study. The enrollment target is 244 participants. The study started on 2023-02-01. Estimated completion is 2027-12-31.
What conditions does trial NCT05983185 study?
This clinical trial studies the following conditions: Spatial Neglect After Right Brain Stroke.
What interventions are being tested in trial NCT05983185?
The interventions under investigation include: Prism adaptation therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05983185?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05983185 being conducted?
This trial has 3 study locations across Georgia, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05983185's enrollment target sits among peer trials
244 438th of 2000 higher than 1,563 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI